Frequently Asked Questions

The Regenerative Approach is a minimally invasive treatment in regenerative medicine that uses stem cells to repair, restore, replace, and regenerate damaged tissues and cells. Stem cells are the body's natural repair mechanism—they maintain tissue health and initiate healing when injury or disease occurs.

Stem cells are undifferentiated cells that have the remarkable potential to develop into many different cell types in the body. They serve as a repair system, capable of dividing essentially without limit to replenish other cells. When a stem cell divides, each new cell has the potential either to remain a stem cell or to become another type of cell with a more specialized function.

The main types include: Adult Stem Cells (harvested from bone marrow, blood, or adipose tissue), Umbilical Cord Blood Stem Cells (collected from donated umbilical cords), Mesenchymal Stem Cells (MSCs) found in bone marrow, adipose tissue, and umbilical cord, and Induced Pluripotent Stem Cells (iPSCs) which are adult cells reprogrammed to behave like embryonic stem cells.

Mesenchymal stem cells are special cells capable of transforming into various cell types, including bone, cartilage, muscle, and nerve cells. Umbilical cord tissue provides a potent and ethically acceptable source of these stem cells. MSCs from umbilical cords are young and vibrant, exhibiting a high capacity for regeneration and repair.

Umbilical cord stem cells are preferred because they are ethically sourced (collected after healthy births, causing no harm), have high potency with greater regenerative abilities than adult stem cells, carry low risk of rejection due to immunomodulatory properties, have higher proliferative capacity, and collection is non-invasive.

Regenerative medicine approach involves transplanting stem cells to replace or repair damaged cells and tissues. The cells are harvested, processed and purified in a laboratory, then introduced into the patient's body through injection or IV infusion. Once in place, stem cells differentiate into specific cell types needed and release growth factors that promote healing.

The Regenerative Approach is generally considered safe when performed by qualified medical professionals using proper protocols. Adult regenerative medicine approach, particularly using MSCs, has a low risk of complications. However, as with any medical procedure, there are potential risks that your medical team will discuss with you.

Potential side effects are typically mild and may include: mild discomfort at the injection site, temporary swelling or bruising, mild fever or flu-like symptoms for 1-2 days, and fatigue. Serious complications are rare when treatment is performed by qualified professionals using properly sourced cells.

Exosomes are nano-sized extracellular vesicles (30-150 nanometers) released by cells, especially stem cells. They act as cellular messengers, carrying proteins, RNA, miRNA, growth factors, and signaling molecules to other cells.

While regenerative medicine approach uses living cells, exosome therapy uses cell-free nano-vesicles derived from stem cells. Exosomes cannot replicate (no tumor risk), can be stored long-term, contain approximately 3x more concentrated growth factors than stem cells, have lower rejection risk, and act more rapidly by directly influencing cellular functions.

Exosome therapy delivers concentrated regenerative signals to damaged tissues. These vesicles reduce inflammation, promote cell proliferation and differentiation, stimulate new blood vessel formation, modulate immune responses, and enhance tissue repair by activating stem cells and reprogramming damaged cells.

Exosome therapy shows promise for orthopedic conditions (joint pain, osteoarthritis), neurological disorders (Alzheimer's, Parkinson's, stroke), cardiovascular disease, autoimmune conditions, aesthetic applications (skin rejuvenation, hair loss), and chronic pain conditions.

Exosomes can be administered through several methods depending on the condition: direct injection (for joints, hair loss, wounds), intravenous (IV) infusion (for systemic conditions), topical application (for skin treatments), or intranasal delivery (for neurological conditions).

Most patients experience minimal discomfort. For injection-based treatments, topical numbing cream is applied first. IV administration is similar to a standard infusion. Post-treatment, some mild soreness may occur for 1-2 days. Most patients resume normal activities immediately.

Results vary by condition and individual. Initial response (pain relief, reduced inflammation) is often seen within 2-4 weeks. Peak healing effects occur at 3-6 months, with continued regenerative effects for 9-12 months or longer. Some patients may benefit from maintenance treatments.

Exosome therapy is generally considered safe when sourced from certified donors, produced under GMP standards, and administered by qualified healthcare providers. Benefits include being cell-free (no tumor growth risk), hypo-immunogenic (low rejection risk), and minimally invasive.

Stem cell and exosome therapies can address osteoarthritis, joint injuries, cartilage damage, tendon tears, ligament injuries, bone fractures, sports injuries, degenerative disc disease, and chronic joint pain.

Regenerative medicine approach shows promise for various neurological conditions including spinal cord injuries, stroke recovery, Parkinson's disease, Alzheimer's disease, multiple sclerosis, traumatic brain injury, ALS, and peripheral neuropathy.

The Regenerative Approach is being used for heart failure, post-heart attack recovery, peripheral artery disease, ischemic heart disease, cardiomyopathy, and vascular regeneration.

Yes, stem cells have immunomodulatory properties that can help with autoimmune conditions including rheumatoid arthritis, lupus, Crohn's disease, type 1 diabetes, multiple sclerosis, and inflammatory bowel disease.

Research shows promise for regenerative medicine approach in diabetes management, particularly in regenerating insulin-producing cells and reducing complications. It may help improve blood sugar control and reduce the need for medications in some patients.

The Regenerative Approach is being researched for chronic kidney disease, helping to regenerate damaged kidney tissue, reduce inflammation, and potentially slow disease progression. Results vary by individual and disease stage.

Stem cells show promise for liver cirrhosis, hepatitis-related damage, and liver failure. MSCs can help reduce liver inflammation, promote tissue regeneration, and improve liver function in suitable candidates.

Yes, regenerative therapies can address signs of aging including skin rejuvenation, improved energy and vitality, enhanced cognitive function, better immune response, and overall cellular regeneration throughout the body.

During your initial consultation, our medical team conducts a comprehensive evaluation including your complete medical history, physical examination, review of existing medical records and imaging, discussion of your approach goals and expectations, and determination of the most appropriate treatment protocol.

Pre-treatment assessment typically includes blood tests (complete blood count, chemistry panel), infectious disease screening, imaging studies (MRI, X-ray, CT scan as needed), cardiac evaluation if required, and any condition-specific diagnostics.

For autologous therapy, stem cells are collected from your own body through bone marrow aspiration (typically from the hip), blood draw, or liposuction for adipose tissue. For allogeneic therapy, we use ethically sourced donor cells from umbilical cord tissue.

Stem cells can be administered via intravenous (IV) infusion for systemic conditions, direct injection into affected joints or tissues, intrathecal injection (into spinal fluid) for neurological conditions, or a combination of methods for optimal results.

A single treatment session typically takes 1-3 hours depending on the administration method. The complete treatment program, including evaluation and follow-up, usually spans 5-10 days for international patients.

Most regenerative medicine applications are performed on an outpatient basis without hospitalization. However, some complex cases or combination treatments may require short-term observation. Our team will discuss your specific needs during consultation.

Recovery is typically minimal. Most patients can resume light activities immediately and normal activities within 24-48 hours. Strenuous exercise should be avoided for 1-2 weeks. Your medical team will provide specific post-treatment guidelines.

The number of treatments varies by condition and individual response. Some patients see significant results with a single treatment, while others may benefit from a series of 2-4 treatments spaced 4-8 weeks apart. Maintenance treatments may be recommended annually.

Results timeline varies by condition. Some patients notice initial improvements within 2-4 weeks, while maximum benefits typically develop over 3-6 months as tissue regeneration occurs. Some conditions may show continued improvement for up to 12 months.

Results can last from 6 months to several years depending on the condition treated, individual health factors, and lifestyle. Many patients experience lasting benefits, though some conditions may benefit from periodic maintenance treatments.

Success rates vary by condition, but clinical studies show significant improvement in 70-90% of patients for conditions like osteoarthritis. Individual results depend on disease severity, overall health, age, and adherence to post-treatment recommendations.

Some patients are able to reduce or discontinue certain medications as their condition improves, but this should only be done under the guidance of your treating physician. Never stop medications without medical supervision.

If initial results are limited, additional treatments may be recommended. Our team monitors your progress and adjusts protocols as needed. Some patients respond more slowly than others, and alternative approaches may be considered.

While most patients experience positive outcomes, results are not guaranteed. Factors affecting outcomes include disease severity, duration of condition, overall health, age, and individual biological response. Our team works to optimize your chances of success.

Good candidates are typically in generally stable health, have a condition that may respond to regenerative therapy, are committed to the care process and follow-up care, and have realistic expectations about outcomes. Age is considered but is not an absolute barrier.

While there are no absolute age limits, ideal candidates are often under 75 years old with good overall health. Younger patients may have better regenerative capacity, but older patients can still benefit significantly from treatment.

Patients with active cancer or those in remission for less than 5 years are generally not candidates for regenerative medicine approach. Each case is evaluated individually, and cancer history should be disclosed during consultation.

Diabetes is not a contraindication; in fact, regenerative medicine approach may help manage diabetes and its complications. Patients with well-controlled diabetes can be good candidates. Uncontrolled diabetes may need to be addressed first.

Blood thinning medications may need to be adjusted temporarily before treatment. Our medical team will provide specific instructions based on your medications and condition. Never stop any medication without medical guidance.

General exclusions include active cancer, active systemic infections, severe organ failure, pregnancy, certain blood disorders, and uncontrolled chronic conditions. Each case is evaluated individually during consultation.

Risks are generally low and may include infection at injection/harvest site (rare), bleeding or bruising, mild allergic reactions, temporary flu-like symptoms, and localized discomfort. Serious complications are rare with properly administered therapy.

Mesenchymal stem cells have low immunogenicity, meaning the risk of rejection is minimal. For autologous treatments using your own cells, there is virtually no rejection risk. Donor cells are carefully screened and processed to minimize any immune response.

Adult mesenchymal stem cells do not carry a risk of tumor formation. Unlike embryonic stem cells, MSCs do not have unlimited replication capacity. This is one reason MSCs are the preferred cell type for regenerative therapies.

Long-term studies of MSC therapy have not shown significant adverse effects. The therapy has been used for decades in various applications. However, as with any medical treatment, ongoing research continues to monitor long-term outcomes.

Our stem cell processing follows strict protocols including sterile handling, contamination testing, cell viability verification, proper storage conditions, and documentation throughout the process. We adhere to international quality standards.

All cells undergo rigorous testing for infectious diseases, contamination, and viability. Donor cells are sourced from thoroughly screened, healthy donors. Laboratory processing follows GMP (Good Manufacturing Practice) standards.

Costs vary depending on the condition, treatment protocol, and number of sessions required. We provide detailed cost estimates during consultation. While not inexpensive, many patients find the investment worthwhile for improved quality of life.

Most insurance plans do not cover regenerative medicine approach as it is still considered investigational for many conditions. However, some associated costs (consultations, imaging, lab tests) may be partially covered. We recommend checking with your insurance provider.

Preparation includes completing required medical evaluations, stopping certain medications as advised (like NSAIDs), staying hydrated, maintaining a healthy diet, getting adequate rest, and arranging transportation for treatment day.

Avoid anti-inflammatory medications (NSAIDs) for 1-2 weeks before treatment, smoking, excessive alcohol, and any activities that could cause injury. Follow all pre-treatment instructions provided by your medical team.

Post-treatment recommendations include avoiding NSAIDs for 2-4 weeks, limiting strenuous activity for 1-2 weeks, staying hydrated, attending follow-up appointments, and reporting any unusual symptoms to your medical team.

Most patients can travel within 1-2 days after treatment. We recommend staying in Istanbul for 2-3 days after your final treatment session for observation and any needed follow-up before returning home.

Physical therapy may be recommended for orthopedic conditions to maximize treatment benefits. Your medical team will provide specific recommendations based on your condition and treatment goals.

Yes, regenerative approaches may often be combined with other treatments including physical therapy, PRP (Platelet-Rich Plasma), exosome therapy, and conventional medical treatments for enhanced results.

StemCell Longevita offers cutting-edge stem cell therapies with experienced medical professionals, state-of-the-art facilities in Istanbul, personalized care plans, comprehensive patient support, and competitive pricing.

Istanbul is a world-renowned medical tourism destination offering advanced medical facilities, experienced specialists, affordable treatment costs compared to Western countries, rich culture and hospitality, and easy international accessibility.

We offer comprehensive support including airport transfers, accommodation assistance, translation services, visa support if needed, 24/7 patient coordination, and follow-up care arrangements with local physicians in your home country.

You can schedule a consultation through our website contact form, WhatsApp (+90 532 413 11 43), or phone (+44 7491 068686 UK / +90 532 413 11 43 TR). Our team will respond within 24 hours to discuss your needs and arrange an evaluation.

Yes, we offer virtual consultations via video call for international patients. This allows our medical team to review your case, discuss treatment options, and provide recommendations before you travel to Istanbul.

Our medical team consists of board-certified physicians with specialized training in regenerative medicine, years of experience in regenerative medicine approach, ongoing education in the latest advances, and membership in professional medical organizations.